An expert panel reviews the causes of Alzheimer disease, as well as strategies used to detect mild cases and cognitive impairment.

At the American Academy of Neurology Annual Meeting held in Philadelphia, Pennsylvania, Jeffrey L. Cummings, MD, ScD, the director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas, spoke with NeurologyLive in an interview to discuss therapies currently being investigated for the treatment of Alzheimer disease.

The National League for Nursing has named UNLV's School of Nursing as a Center of Excellence for 2019. It's one of just 10 programs nationwide to receive the award.

Next summer, NASA will launch its fifth rover to Mars to look for signs of ancient life on the Red Planet. But the latest robotic mission, simply dubbed Mars 2020, has another goal: figuring out how to sustain human life in the harsh and unforgiving environment on Mars. Hitching a ride on the rover are devices to convert the abundant carbon dioxide on Mars into oxygen and a ground-penetrating radar to hunt for underground ice as a future water supply.

Dr. Neal Malik reads the latest health and fitness blogs to help optimize your life. Today, Samantha Coogan — director of UNLV's Didactic Program in Nutrition & Dietetics and president of the Nevada Academy of Nutrition and Dietetics — explains how putting a halt on sweet treats affects the body.

Sending humans to Mars could leave astronauts with neurological problems, according scientists who studied mice in conditions which they claimed replicate deep space.

The Cleveland Clinic’s fourth annual Alzheimer disease (AD) drug development pipeline presents a new round of clinical trials to give clinicians a comprehensive look at current research in the US. The investigators, led by Jeffrey Cummings, MD, ScD, director emeritus of Cleveland Clinic Lou Ruvo Center for Brain Health, identified all pharmacologic Alzheimer trials currently in development from Clinicaltrials.gov. They found 132 agents currently in 156 clinical trials— 28 of which are in 42 phase 3 trials; 74 in 83 phase 2 trials; and 30 in 31 phase 1 trials.

At the 2019 American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania, Jeffrey Cummings, MD, ScD, director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair for department of brain health at the University of Nevada Las Vegas, spoke with NeurologyLive in an interview to discuss several hot topics in Alzheimer disease.

Among the sugar withdrawal symptoms that affect those who decide to eliminate it are headaches, stomach pains or intestinal changes.

Deleting sugar from a diet can significantly affect better health, better look, and results in physical activity.

Cutting excess sugar from the diet can improve health and work performance. This was underlined by Samantha Coogan, president of the Nevada Academy of Nutrition and Dietetics and a researcher at the University of Nevada Las Vegas.

Are you the one whose candy tooth is constantly falling? It is no wonder, because the added sugar is present in any food, and the candy shelves are attractively lurking close to the cash register of every shop. It is hard to avoid sweet treats and getting sugar in the diet at all. But should we try to reduce? Or maybe even stop using (added) sugar?